FDA Approves Long-Acting Flea and Tick Treatment for Dogs
TL;DR Summary
The FDA has approved Bravecto Quantum, a 12-month flea and tick preventative for dogs, administered via a single injection by a veterinarian, offering long-term protection and convenience, with some potential side effects to consider.
- FDA approves 12-month flea treatment for dogs, marking veterinary breakthrough ABC News - Breaking News, Latest News and Videos
- FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health Yahoo Finance
- First long-acting flea and tick treatment is FDA-approved for dogs DVM360
- Merck Animal Health gets FDA nod for Bravecto Quantum (MRK:NYSE) Seeking Alpha
- Merck Animal Health's Flea-and-Tick Treatment Approved in U.S. MarketScreener
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 2 min read
Condensed
90%
353 → 34 words
Want the full story? Read the original article
Read on ABC News - Breaking News, Latest News and Videos